Chairman of the Board and CEO of BioScrip Inc. (BIOS) Richard H Friedman sells 10,000 shares of BIOS on 12/01/2009 at an average price of $7.69 a share.

BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services, both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $290.4 million; its shares were traded at around $7.49 with a P/E ratio of 17.9 and P/S ratio of 0.2.

BIOS is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES.

Insiders' Positions with BIOS

• Sell:: Chairman of the Board and CEO Richard H Friedman sold 8,302 shares of BIOS stock on 11/16/2009 at the average price of 9, the price of the stock has decreased by 16.78% since


• Sell:: Chairman of the Board and CEO Richard H Friedman sold 85,000 shares of BIOS stock on 11/09/2009 at the average price of 8.01, the price of the stock has decreased by 6.49% since


• Sell:: Chairman of the Board and CEO Richard H Friedman sold 58,000 shares of BIOS stock on 11/04/2009 at the average price of 7.73, the price of the stock has decreased by 3.1% since


• Sell:: Chairman of the Board and CEO Richard H Friedman sold 7,861 shares of BIOS stock on 10/14/2009 at the average price of 7, the price of the stock has increased by 7% since


• Sell:: Chairman of the Board and CEO Richard H Friedman sold 22,139 shares of BIOS stock on 10/08/2009 at the average price of 7, the price of the stock has increased by 7% since

Insiders' Positions with BIOS

• Sell:: 10% Owner William J Nasgovitz sold 13,600 shares of BIOS stock on 12/01/2009 at the average price of 7.69, the price of the stock has decreased by 2.6% since


• Sell:: 10% Owner William J Nasgovitz sold 62,000 shares of BIOS stock on 11/25/2009 at the average price of 7.78, the price of the stock has decreased by 3.73% since


• Sell:: 10% Owner William J Nasgovitz sold 24,400 shares of BIOS stock on 11/23/2009 at the average price of 7.83, the price of the stock has decreased by 4.34% since


• Sell:: Executive Vice President Thomas Ordemann sold 41,260 shares of BIOS stock on 11/11/2009 at the average price of 8.56, the price of the stock has decreased by 12.5% since


• Sell:: Executive Vice President Thomas Ordemann sold 41,260 shares of BIOS stock on 11/11/2009 at the average price of 8.56, the price of the stock has decreased by 12.5% since

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool